-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MApfzixaP5ihF+DzIRXi/VIylQ+bWkDghq9NaTXU5akE18wM5Sd6SEvS6M+iBl/W NOHgbkj0pHTrAdgE92qDyg== 0000909012-10-000152.txt : 20100216 0000909012-10-000152.hdr.sgml : 20100215 20100216161421 ACCESSION NUMBER: 0000909012-10-000152 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091231 FILED AS OF DATE: 20100216 DATE AS OF CHANGE: 20100216 EFFECTIVENESS DATE: 20100216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PERCEPTIVE ADVISORS LLC CENTRAL INDEX KEY: 0001224962 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-10438 FILM NUMBER: 10607977 BUSINESS ADDRESS: STREET 1: 499 PARK AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 646-205-5340 MAIL ADDRESS: STREET 1: 499 PARK AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 13F-HR 1 t305754.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F-HR Form 13F COVER PAGE Report for the Calendar Year of Quarter Ended: December 31, 2009 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Perceptive Advisors LLC Address: 499 Park Ave, 25th Floor New York, NY 10022 Form 13F File Number: 28-10438 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Joseph Edelman Title: Managing Member Phone: (646) 205-5342 Signature, Place, and Date of Signing: /s/ Joseph Edelman New York, NY February 16, 2010 - ------------------ ------------ ----------------- [Signature] [City, State] [Date] Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 ----------- Form 13F Information Table Entry Total: 97 ----------- Form 13F Information Table Value Total: $437,816 ----------- (thousands) List of Other Included Managers: {None}
SHRS OR TITLE OF VALUE PRN SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER CLASS CUSIP (X1000) AMOUNT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE - ------------------------------------------------------------------------------------------------------------------------------------ AMAG PHARMACEUTICALS INC COM 00163U106 3,803 100,000 SH C SOLE 100,000 AMAG PHARMACEUTICALS INC COM 00163U106 3,803 100,000 SH P SOLE 100,000 ATS MED INC NOTE 6.000%10/1 002083AB9 1,238 1,250,000 PRN SOLE 1,250,000 AVI BIOPHARMA INC COM 002346104 4,148 2,841,019 SH SOLE 2,841,019 ACHILLION PHARMACEUTICALS IN COM 00448Q201 156 50,000 SH SOLE 50,000 ALEXION PHARMACEUTICALS INC COM 015351109 23,607 483,546 SH SOLE 483,546 ALKERMES INC COM 01642T108 1,882 200,000 SH C SOLE 200,000 ALKERMES INC COM 01642T108 2,823 300,000 SH P SOLE 300,000 ALLSCRIPT MISYS HEALTCAR SOL COM 01988P108 1,416 70,000 SH SOLE 70,000 AMEDISYS INC COM 023436108 9,720 200,000 SH C SOLE 200,000 AMYLIN PHARMACEUTICALS INC COM 032346108 7,095 500,000 SH C SOLE 500,000 AMYLIN PHARMACEUTICALS INC COM 032346108 9,933 700,000 SH P SOLE 700,000 ARIAD PHARMACEUTICALS INC COM 04033A100 868 380,800 SH SOLE 380,800 ATHENAHEALTH INC COM 04685W103 4,072 90,000 SH SOLE 90,000 AUXILIUM PHARMACEUTICALS INC COM 05334D107 2,998 100,000 SH C SOLE 100,000 BIOMIMETIC THERAPEUTICS INC COM 09064X101 4,891 410,000 SH SOLE 410,000 BOSTON SCIENTIFIC CORP COM 101137107 2,250 250,000 SH SOLE 250,000 BRISTOL MYERS SQUIBB CO COM 110122108 505 20,000 SH SOLE 20,000 CIGNA CORP COM 125509109 7,230 205,000 SH SOLE 205,000 CAPITAL SR LIVING CORP COM 140475104 602 120,000 SH SOLE 120,000 CELL THERAPEUTICS INC COM NO PAR 150934503 570 500,000 SH C SOLE 500,000 CELL THERAPEUTICS INC COM NO PAR 150934503 228 200,000 SH P SOLE 200,000 CELL THERAPEUTICS INC COM NO PAR 150934503 684 600,000 SH SOLE 600,000 CELGENE CORP COM 151020104 8,352 150,000 SH P SOLE 150,000 CELGENE CORP COM 151020104 5,568 100,000 SH C SOLE 100,000 CELGENE CORP COM 151020104 5,568 100,000 SH SOLE 100,000 CELSION CORPORATION COM NEW 15117N305 1,079 330,085 SH SOLE 330,085 CEPHALON INC COM 156708109 6,242 100,000 SH C SOLE 100,000 CERNER CORP COM 156782104 8,244 100,000 SH C SOLE 100,000 CHELSEA THERAPEUTICS INTL LT COM 163428105 540 200,000 SH P SOLE 200,000 CHINA NUOKANG BIO-PHARM INC SPONSORED ADS 16949B113 769 98,000 SH SOLE 98,000 CLINICAL DATA INC NEW COM 18725U109 4,673 255,917 SH SOLE 255,917 COMBIMATRIX CORPORATION *W EXP 99/99/999 20009T113 0 50,000 SH SOLE 50,000 CONCEPTUS INC COM 206016107 7,692 410,000 SH SOLE 410,000 CRUCELL N V SPONSORED ADR 228769105 2,422 120,000 SH SOLE 120,000 CYPRESS BIOSCIENCES INC COM PAR $.02 232674507 6,347 1,100,000 SH P SOLE 1,100,000 CYPRESS BIOSCIENCES INC COM PAR $.02 232674507 577 100,000 SH C SOLE 100,000 DENDREON CORP COM 24823Q107 8,684 330,455 SH SOLE 330,455 EMDEON INC CL A 29084T104 1,144 75,000 SH SOLE 75,000 EMERGENT BIOSOLUTIONS INC COM 29089Q105 680 50,000 SH SOLE 50,000 ENZON PHARMACEUTICALS INC COM 293904108 1,053 100,000 SH SOLE 100,000 EXELIXIS INC COM 30161Q104 166 22,518 SH SOLE 22,518 EXPRESS SCRIPTS INC COM 302182100 16,420 190,000 SH SOLE 190,000 GENZYME CORP COM 372917104 8,822 180,000 SH SOLE 180,000 GILEAD SCIENCES INC COM 375558103 12,981 300,000 SH P SOLE 300,000 GILEAD SCIENCES INC COM 375558103 15,218 351,709 SH SOLE 351,709 GTX INC DEL COM 40052B108 2,192 521,800 SH C SOLE 521,800 GTX INC DEL COM 40052B108 2,205 525,000 SH P SOLE 525,000 HMS HLDGS CORP COM 40425J101 5,637 115,771 SH SOLE 115,771 HUMAN GENOME SCIENCES INC COM 444903108 20,030 655,000 SH SOLE 655,000 INCYTE CORP COM 45337C102 1,822 200,000 SH SOLE 200,000 INHIBITEX INC COM 45719T103 457 496,618 SH SOLE 496,618 INTERMUNE INC COM 45884X103 12,471 956,396 SH SOLE 956,396 MANNKIND CORP COM 56400P201 876 100,000 SH P SOLE 100,000 MANNKIND CORP COM 56400P201 876 100,000 SH C SOLE 100,000 MEDICIS PHARMACEUTICAL CORP CL A NEW 584690309 3,517 130,000 SH SOLE 130,000 MEDIFAST INC COM 58470H101 306 10,000 SH SOLE 10,000 MEDIVATION INC COM 58501N101 13,178 350,000 SH C SOLE 350,000 MEDIVATION INC COM 58501N101 11,970 317,923 SH SOLE 317,923 MERIT MED SYS INC COM 589889104 7,504 390,000 SH SOLE 390,000 MICROMET INC COM 59509C105 1,199 180,016 SH SOLE 180,016 MINDRAY MEDICAL INTL LTD SPON ADR 602675100 678 20,000 SH SOLE 20,000 MYLAN INC COM 628530107 1,474 80,000 SH SOLE 80,000 OPTIMER PHARMACEUTICALS INC COM 68401H104 3,068 272,201 SH SOLE 272,201 PDL BIOPHARMA INC COM 69329Y104 1,868 272,300 SH SOLE 272,300 PENWEST PHARMACEUTICALS CO COM 709754105 16,773 6,476,446 SH SOLE 6,476,446 PHARMACYCLICS INC COM 716933106 7,061 2,248,621 SH SOLE 2,248,621 PFIZER INC COM 717081103 350 19,250 SH SOLE 19,250 PHARMATHENE INC COM 71714G102 98 50,000 SH SOLE 50,000 PONIARD PHARMACEUTICALS INC COM NEW 732449301 3,752 2,050,000 SH P SOLE 2,050,000 PROASSURANCE CORP COM 74267C106 1,611 30,000 SH SOLE 30,000 PSIVIDA CORP COM 74440J101 344 95,799 SH SOLE 95,799 QUALITY SYS INC COM 747582104 5,652 90,000 SH SOLE 90,000 RAPTOR PHARMACEUTICAL CORP COM 75382F106 229 125,000 SH SOLE 125,000 RESPONSE GENETICS INC COM 76123U105 503 399,599 SH SOLE 399,599 RIGEL PHARMACEUTICALS INC COM NEW 766559603 951 100,000 SH C SOLE 100,000 ROCKWELL MEDICAL TECH COM 774374102 1,260 163,888 SH SOLE 163,888 SALIX PHARMACEUTICALS INC COM 795435106 9,775 385,000 SH SOLE 385,000 SCICLONE PHARMACEUTICALS INC COM 80862K104 117 50,000 SH SOLE 50,000 SEQUENOM INC COM NEW 817337405 414 100,000 SH P SOLE 100,000 SEQUENOM INC COM NEW 817337405 414 100,000 SH C SOLE 100,000 SHIRE PLC SPONSORED ADR 82481R106 5,870 100,000 SH P SOLE 100,000 SHIRE PLC SPONSORED ADR 82481R106 1,761 30,000 SH SOLE 30,000 SIGA TECHNOLOGIES INC COM 826917106 362 62,490 SH SOLE 62,490 SUPERGEN INC COM 868059106 1,048 400,000 SH C SOLE 400,000 SUPERGEN INC COM 868059106 1,216 464,227 SH SOLE 464,227 TARGACEPT INC COM 87611R306 11,939 571,246 SH SOLE 571,246 3SBIO INC SPONSORED ADR 88575Y105 6,605 482,475 SH SOLE 482,475 UNITED THERAPEUTICS CORP DEL COM 91307C102 12,492 237,264 SH SOLE 237,264 UNITEDHEALTH GROUP INC COM 91324P102 5,029 165,000 SH SOLE 165,000 VANDA PHARMACEUTICALS INC COM 921659108 3,769 335,000 SH SOLE 335,000 VERTEX PHARMACEUTICALS INC COM 92532F100 8,570 200,000 SH C SOLE 200,000 VICAL INC COM 925602104 3,790 1,152,100 SH SOLE 1,152,100 VIVUS INC COM 928551100 4,720 513,000 SH SOLE 513,000 WARNER CHILCOTT PLC IRELAND SHS A G94368100 3,345 117,500 SH SOLE 117,500 WELLPOINT INC COM 94973V107 7,869 135,000 SH SOLE 135,000 ZIOPHARM ONCOLOGY INC COM 98973P101 1,036 350,000 SH SOLE 350,000 437,816
-----END PRIVACY-ENHANCED MESSAGE-----